Want to join the conversation?
For 2016, $CPGX expects to generate between $705-715MM of adjusted EBITDA. Cash Capex is expected to be $1.4-1.6Bil, including maintenance capital. $CPGX's project inventory is expected to drive average annual EBITDA growth of 20% and dividend growth of 15% through 2020.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.